Physician profile
Chad C Perry
NPI 1215015748
$1,701.33
in general payments reported to CMS, 2019-2025
13 companies · $987 in 2025
The $987 reported for 2025 was more than what 95% of General Practice (Dentist) providers received nationally (typical 2025 total: $74.60).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $25.51 · 2020: $31.30 · 2021: $160 · 2022: $76.24 · 2023: $202 · 2024: $220 · 2025: $987.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Gift: $796 · Education: $308 · Food and Beverage: $304.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Gift | $796.43 |
| Education | $308.09 |
| Food and Beverage | $304.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ultradent Products INC | $721.36 | 2025 | Opalescence |
| Straumann USA LLC | $296.99 | 2024-2025 | |
| Align Technology, INC. | $231.26 | 2019-2025 | Invisalign |
| Purelife, LLC | $120.00 | 2022-2024 | |
| Hu-Friedy Mfg. Co., LLC | $108.09 | 2023 | Hu-Friedy |
| Envista Holdings Corporation | $77.63 | 2024-2025 | Harmonize, Optibond Solo Plus |
| Kls-Martin L.P. | $40.00 | 2024 | |
| Benco Dental Supply Co. | $31.30 | 2020 | |
| Biohorizons Implant Systems INC. | $18.40 | 2022 | |
| Philips North America LLC | $18.16 | 2023 | |
| 3m Company | $15.25 | 2023 | 3m Relyx, 3m Filtek, Scotchbond Universal Plus |
| Amgen INC. | $12.39 | 2019 | |
| Voco America INC. | $10.50 | 2023 | Admira Fusion, Voco Profluorid Varnish, Admira Fusion X-Tra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chad Perry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.